The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tumor Multigene Detection Kit Market Research Report 2024

Global Tumor Multigene Detection Kit Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1765152

No of Pages : 96

Ask Your Query

Synopsis
Tumor NGS detection kit is an experimental consumable used in tumor detection

Global Tumor Multigene Detection Kit market is projected to reach US$ 2477.8 million in 2029, increasing from US$ 877 million in 2022, with the CAGR of 16.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tumor Multigene Detection Kit market research.

Key manufacturers engaged in the Tumor Multigene Detection Kit industry include Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx and Burning Rock Medicine, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Tumor Multigene Detection Kit were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tumor Multigene Detection Kit market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tumor Multigene Detection Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Roche Foundation Medicine
  • Illumina Inc.
  • Life Technologies Corporation
  • Thermo Fisher Scientific
  • Memorial Sloan Kettering
  • Novogene
  • Geneseeq
  • AmoyDx
  • Burning Rock Medicine
  • NantHealth
  • Personal Genome Diagnostics
  • GTH.O

Segment by Type

  • Reversible End Termination Sequencing
  • Semiconductor Sequencing
  • Combined Probe Anchored Polymerization Sequencing

Segment by Application

  • Companion Diagnostics
  • Early Cancer Screening
  • Drug Discovery
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Tumor Multigene Detection Kit report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Tumor Multigene Detection Kit Market Overview
1.1 Product Overview and Scope of Tumor Multigene Detection Kit
1.2 Tumor Multigene Detection Kit Segment by Type
1.2.1 Global Tumor Multigene Detection Kit Market Value Comparison by Type (2023-2029)
1.2.2 Reversible End Termination Sequencing
1.2.3 Semiconductor Sequencing
1.2.4 Combined Probe Anchored Polymerization Sequencing
1.3 Tumor Multigene Detection Kit Segment by Application
1.3.1 Global Tumor Multigene Detection Kit Market Value by Application: (2023-2029)
1.3.2 Companion Diagnostics
1.3.3 Early Cancer Screening
1.3.4 Drug Discovery
1.3.5 Other
1.4 Global Tumor Multigene Detection Kit Market Size Estimates and Forecasts
1.4.1 Global Tumor Multigene Detection Kit Revenue 2018-2029
1.4.2 Global Tumor Multigene Detection Kit Sales 2018-2029
1.4.3 Global Tumor Multigene Detection Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tumor Multigene Detection Kit Market Competition by Manufacturers
2.1 Global Tumor Multigene Detection Kit Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tumor Multigene Detection Kit Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tumor Multigene Detection Kit Average Price by Manufacturers (2018-2023)
2.4 Global Tumor Multigene Detection Kit Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tumor Multigene Detection Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Multigene Detection Kit, Product Type & Application
2.7 Tumor Multigene Detection Kit Market Competitive Situation and Trends
2.7.1 Tumor Multigene Detection Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tumor Multigene Detection Kit Players Market Share by Revenue
2.7.3 Global Tumor Multigene Detection Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tumor Multigene Detection Kit Retrospective Market Scenario by Region
3.1 Global Tumor Multigene Detection Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tumor Multigene Detection Kit Global Tumor Multigene Detection Kit Sales by Region: 2018-2029
3.2.1 Global Tumor Multigene Detection Kit Sales by Region: 2018-2023
3.2.2 Global Tumor Multigene Detection Kit Sales by Region: 2024-2029
3.3 Global Tumor Multigene Detection Kit Global Tumor Multigene Detection Kit Revenue by Region: 2018-2029
3.3.1 Global Tumor Multigene Detection Kit Revenue by Region: 2018-2023
3.3.2 Global Tumor Multigene Detection Kit Revenue by Region: 2024-2029
3.4 North America Tumor Multigene Detection Kit Market Facts & Figures by Country
3.4.1 North America Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.4.3 North America Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Multigene Detection Kit Market Facts & Figures by Country
3.5.1 Europe Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.5.3 Europe Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Multigene Detection Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tumor Multigene Detection Kit Market Facts & Figures by Country
3.7.1 Latin America Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.7.3 Latin America Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tumor Multigene Detection Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Multigene Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tumor Multigene Detection Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tumor Multigene Detection Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Multigene Detection Kit Sales by Type (2018-2029)
4.1.1 Global Tumor Multigene Detection Kit Sales by Type (2018-2023)
4.1.2 Global Tumor Multigene Detection Kit Sales by Type (2024-2029)
4.1.3 Global Tumor Multigene Detection Kit Sales Market Share by Type (2018-2029)
4.2 Global Tumor Multigene Detection Kit Revenue by Type (2018-2029)
4.2.1 Global Tumor Multigene Detection Kit Revenue by Type (2018-2023)
4.2.2 Global Tumor Multigene Detection Kit Revenue by Type (2024-2029)
4.2.3 Global Tumor Multigene Detection Kit Revenue Market Share by Type (2018-2029)
4.3 Global Tumor Multigene Detection Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tumor Multigene Detection Kit Sales by Application (2018-2029)
5.1.1 Global Tumor Multigene Detection Kit Sales by Application (2018-2023)
5.1.2 Global Tumor Multigene Detection Kit Sales by Application (2024-2029)
5.1.3 Global Tumor Multigene Detection Kit Sales Market Share by Application (2018-2029)
5.2 Global Tumor Multigene Detection Kit Revenue by Application (2018-2029)
5.2.1 Global Tumor Multigene Detection Kit Revenue by Application (2018-2023)
5.2.2 Global Tumor Multigene Detection Kit Revenue by Application (2024-2029)
5.2.3 Global Tumor Multigene Detection Kit Revenue Market Share by Application (2018-2029)
5.3 Global Tumor Multigene Detection Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche Foundation Medicine
6.1.1 Roche Foundation Medicine Corporation Information
6.1.2 Roche Foundation Medicine Description and Business Overview
6.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolio
6.1.5 Roche Foundation Medicine Recent Developments/Updates
6.2 Illumina Inc.
6.2.1 Illumina Inc. Corporation Information
6.2.2 Illumina Inc. Description and Business Overview
6.2.3 Illumina Inc. Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Illumina Inc. Tumor Multigene Detection Kit Product Portfolio
6.2.5 Illumina Inc. Recent Developments/Updates
6.3 Life Technologies Corporation
6.3.1 Life Technologies Corporation Corporation Information
6.3.2 Life Technologies Corporation Description and Business Overview
6.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolio
6.3.5 Life Technologies Corporation Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Memorial Sloan Kettering
6.5.1 Memorial Sloan Kettering Corporation Information
6.5.2 Memorial Sloan Kettering Description and Business Overview
6.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolio
6.5.5 Memorial Sloan Kettering Recent Developments/Updates
6.6 Novogene
6.6.1 Novogene Corporation Information
6.6.2 Novogene Description and Business Overview
6.6.3 Novogene Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novogene Tumor Multigene Detection Kit Product Portfolio
6.6.5 Novogene Recent Developments/Updates
6.7 Geneseeq
6.6.1 Geneseeq Corporation Information
6.6.2 Geneseeq Description and Business Overview
6.6.3 Geneseeq Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Geneseeq Tumor Multigene Detection Kit Product Portfolio
6.7.5 Geneseeq Recent Developments/Updates
6.8 AmoyDx
6.8.1 AmoyDx Corporation Information
6.8.2 AmoyDx Description and Business Overview
6.8.3 AmoyDx Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AmoyDx Tumor Multigene Detection Kit Product Portfolio
6.8.5 AmoyDx Recent Developments/Updates
6.9 Burning Rock Medicine
6.9.1 Burning Rock Medicine Corporation Information
6.9.2 Burning Rock Medicine Description and Business Overview
6.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolio
6.9.5 Burning Rock Medicine Recent Developments/Updates
6.10 NantHealth
6.10.1 NantHealth Corporation Information
6.10.2 NantHealth Description and Business Overview
6.10.3 NantHealth Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.10.4 NantHealth Tumor Multigene Detection Kit Product Portfolio
6.10.5 NantHealth Recent Developments/Updates
6.11 Personal Genome Diagnostics
6.11.1 Personal Genome Diagnostics Corporation Information
6.11.2 Personal Genome Diagnostics Tumor Multigene Detection Kit Description and Business Overview
6.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolio
6.11.5 Personal Genome Diagnostics Recent Developments/Updates
6.12 GTH.O
6.12.1 GTH.O Corporation Information
6.12.2 GTH.O Tumor Multigene Detection Kit Description and Business Overview
6.12.3 GTH.O Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.12.4 GTH.O Tumor Multigene Detection Kit Product Portfolio
6.12.5 GTH.O Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Multigene Detection Kit Industry Chain Analysis
7.2 Tumor Multigene Detection Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Multigene Detection Kit Production Mode & Process
7.4 Tumor Multigene Detection Kit Sales and Marketing
7.4.1 Tumor Multigene Detection Kit Sales Channels
7.4.2 Tumor Multigene Detection Kit Distributors
7.5 Tumor Multigene Detection Kit Customers
8 Tumor Multigene Detection Kit Market Dynamics
8.1 Tumor Multigene Detection Kit Industry Trends
8.2 Tumor Multigene Detection Kit Market Drivers
8.3 Tumor Multigene Detection Kit Market Challenges
8.4 Tumor Multigene Detection Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock